January 9, 2019

OBI Pharma, Inc. to Present at the J.P. Morgan Healthcare Conference

[…]
November 21, 2018

OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer

[…]
September 19, 2018

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)

[…]